Sunday, November 29, 2020

COVID-19 vaccine | SII rejects claims of Covishield#39;s adverse effect, threatens to seek damages in excess of Rs 100 crore

COVID-19 vaccine | SII rejects claims of Covishield#39;s adverse effect, threatens to seek damages in excess of Rs 100 crore The volunteer is falsely laying the blame for his medical problems on the trial of COVID-19 vaccine Covishield, said Serum Institute of India

from Moneycontrol Business News https://www.moneycontrol.com/news/business/covid-19-vaccine-|-sii-rejects-claimscovishield39s-adverse-effect-threatens-to-seek-damagesexcessrs-100-crore_14538241.html
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Short-term volatility may persist, but FII flows and economic activity to keep sentiment positive: Vikas Khemani

Vikas Khemani of Carnelian Asset Management remains optimistic about Indian markets, citing a strong domestic growth story and the resolutio...